CB07-Exatecan is an ADC drug-Linker conjugate that can be used for the synthesis of ADCs. ADC conjugated with CB07-Exatecan and trastuzumab inhibits the growth of HER2-positive cancer cells. CB07-Exatecan can be used in cancer research[1].
Molecular Weight:
1472.56
Purity:
98.97
CAS Number:
[2879247-31-9]
Formula:
C71H94FN11O22
Target:
Drug-Linker Conjugates for ADC,Topoisomerase
Application Notes:
ADC Related
* VAT and and shipping costs not included. Errors and price changes excepted